Investor Overview
VYNE Therapeutics® is a biopharmaceutical company.
Committed to addressing unmet needs and providing new options for patients with immuno-inflammatory conditions.
NASDAQ-GS: VYNE
0.51
Jul. 24, 2026 16:00:01- Change -0.4144 (-44.87763%)
- Volume 2,946,221
- Today's Open 0.4926
- Previous Close 0.9234
- Today's High 0.5488
- Today's Low 0.47
- 52 Week High 79.75
- 52 Week Low 0.47